Research of acute toxicity of the drug HEXIA

Journal Title: Фармацевтичний журнал - Year 2016, Vol 6, Issue 6

Abstract

Diseases of the genitourinary system caused by pathogenic and potentially pathogenic microorganisms, which result into disbiosis of urinary organs, remain an urgent problem of dermatovenereology, gynecology and urology, despite the fact that there is a significant number of available and new medicines to treat them. The aim of the work was to determine the safety of the preparation Hexia within experiments on animals. The acute toxicity of Hexia has been determined on 20 adult female laboratory rats under the conditions of hourly intravaginal administration of the preparation with a dose of 70 mg/kg during 12 hours, as well as on 20 female laboratory rats and 20 female laboratory mice with a single intragastric administration in a dose of 145 mg/kg. The assessment of the impact of the preparation studied was performed on the basis of the following parameters: a) mortality (terms of death of animals in each group, on a daily basis); b) assessment of toxicity development (on a daily basis), including an assessment of the visual environment of the area of injection (the presence of irritation, redness, edema); c) dynamics of body weight changes (in the initial state, on the 4th, 7th and 14th day after application); d) macroscopy of internal organs, mass coefficients of internal organs within rats (on the 14th day). It has been found that intravaginal application and a single intragastric administration of the preparation Hexia in the form of pessaries, which contain chlorhexidine digluconate, does not result into death of rats and mice, brings no effect on body weight gain, integrative parameters of the functional state of laboratory animals as well as on the relative mass of internal organs, which implies the absence of significant toxic effect of the preparation. Thus, the results of the studies conducted indicate that the median lethal dose for Hexia in case of intravaginal application to rats or intragastric administration to rats and mice is beyond the rate of 500 mg/kg. According to the toxicological classification of substances Hexia belongs to the IV class of toxicity – low toxic substances.

Authors and Affiliations

V. L. Karbovskyy, I. A. Shevchuk, O. V. Kurkina, T. Ye. Makovska

Keywords

Related Articles

A study of job satisfaction of pharmaceutical workers

The effectiveness of the functioning of any pharmaceutical institution and its staff depends significantly on the work satisfaction of the pharmacists, that is, their relationship to work and its individual components. O...

Bioinformation analysis of rotavirus vaccine efficiency

A couple of studies have shown that viruses cause from 25 to 60% of acute intestinal infections (AII) cases, among which rotaviruses play a leading role in the structure of children's AII of viral etiology. According to...

Study on domestic market of medicinal products of plant origin

The popularity of herbal remedies and medicines, with the participation of biologically active substances from plants is traditionally high. The annual increase of the domestic market for herbal remedies is due to the pr...

The rationale for the method of administration of decamethoxinum and lidocaine hydrochloride in the basis of drug films

It is known that the efficiency of the medicine depends on pharmaceutical factors, in particular on the technology of preparation. The choice of optimal technology preparation of a drug depends on such factors as the met...

Influence of excipients in antiglaukoma eye drops on quality of life index based on criteria of side effects frequency

Following the growth of overall morbidity, environmental degradation, social and economic vulnerability of the population, the demand for the effective and cheap medicines, which can provide an individual approach to the...

Download PDF file
  • EP ID EP565659
  • DOI 10.32352/0367-3057.6.16.06
  • Views 59
  • Downloads 0

How To Cite

V. L. Karbovskyy, I. A. Shevchuk, O. V. Kurkina, T. Ye. Makovska (2016). Research of acute toxicity of the drug HEXIA. Фармацевтичний журнал, 6(6), 88-94. https://europub.co.uk./articles/-A-565659